Upcoming: Crohn’s & Colitis Congress 2021

“The Gaps That Remain: Unmet needs in the treatment of ulcerative colitis,” an Arena-Sponsored Showcase with Dr. Remo Panaccione, University of Calgary. Thursday, January 21 from 4:10-4:40pm EST*

This showcase is organized and sponsored by Arena Pharmaceuticals, Inc. This symposium is not affiliated with Crohn’s & Colitis Congress (CCC).

Register Now

Arena’s poster at Advances in IBD (AIBD) available on the congress Virtual Platform

P0151

Effect of Etrasimod on Circulating Lymphocyte Subsets: Data From a Randomized Phase 1 Study in Healthy Japanese and Caucasian Men

Posters may discuss investigational drugs, which have not been approved by any regulatory agency. These have not been peer-reviewed. Additional studies are needed to evaluate safety and efficacy.

Our
work

We are passionate, fearless, and always hungry for change. Our ambition is to improve the lives of the patients we aim to help.

Clinical Trials

Explore GI Programs

Publications

Access our Library

Investigational Drugs

Learn More About Etrasimod and Olorinab

The science of
inflammatory bowel
disease (IBD)

video-thumb

The science of
inflammatory bowel
disease (IBD)

We are evaluating an oral, selective S1P receptor modulator for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD).

arena-of-care-logo

Working to help meet
the needs of patients

Our work is focused on a singular purpose: to support what matters most to patients and the communities that serve them. This is our Arena of Care™.

arena-of-care-logo
Learn More, Including
How to Apply

For Medical Information, contact us at medinfo@arenapharm.com